EDGAR Filing Documents for 0001396814-18-000012

Form 8-K - Current report:

SEC Accession No. 0001396814-18-000012

Filing Date

2018-05-03

Accepted

2018-05-03 08:05:13

Documents

Period of Report

2018-05-03

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kxpcrxq12018earningscall.htm	8-K	25328
2	EXHIBIT 99.1	pcrx-03312018x991.htm	EX-99.1	180977
3		paciralogo1a09.jpg	GRAPHIC	76073
	Complete submission text file	0001396814-18-000012.txt		312495

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 18801849
SIC: 2834 Pharmaceutical Preparations